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Cancer screeningOur conceptual model demonstrates our goal to investigate the impact of clinical decision support (CDS)
utilization on cancer screening improvement strategies in the community health care (CHC) setting. We
employed a dualmodeling technique using both statistical and computationalmodeling to evaluate impact.
Our statisticalmodelusedtheSpearman’sRhotest toevaluate thestrengthof relationshipbetweenourprox-
imal outcomemeasures (CDSutilization) against our distal outcomemeasure (provider self-reported cancer
screening improvement). Our computational model relied on network evolution theory and made use of a
tool called Construct-TM to model the use of CDS measured by the rate of organizational learning. We
employed the use of previously collected survey data fromcommunity health centers CancerHealthDispar-
ities Collaborative (HDCC). Our intent is to demonstrate the added valued gained by using a computational
modeling tool in conjunction with a statistical analysis when evaluating the impact a health information
technology, in the form of CDS, on health care quality process outcomes such as facility-level screening
improvement. Signiﬁcant simulated disparities in organizational learningover timewere observed between
community health centers beginning the simulation with high and low clinical decision support capability.
 2014 Elsevier Inc. All rights reserved.1. Introduction
According to the National Cancer Institute (NCI), an estimated
1,660,290 people in the United States were diagnosed with cancer
in 2013, and, of these, 580,350 are expected to die of cancer [1].
Current estimates as to the number of these deaths that could have
been avoided through screening vary from 3% to 35% depending
upon assumptions regarding disease progression, prognosis, and
environmental and lifestyle factors [2]. Three types of cancer
screening—(1) the Pap test for cervical, (2) the mammography for
breast, and (3) a battery of tests for colorectal cancer screening—
have been found to detect cancer in its early stages and improve
survival rates [3–11]. In spite of increased screening rates, Rutten
et al. report that colorectal cancer screening rates found in their
research lagged behind both Pap tests and mammography screen-
ings [12]. Colorectal cancer screening performance rates are based
on national guidelines and evidence-based best practices [3,5,13].
The American Cancer Society and the U.S. Preventive Services Task
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tal cancer, that women over Age 40 receive annual mammograms,
and that women be administered a Pap test at two-year intervals
beginning either at the onset of sexual activity or at Age 21
[4,14]. Although guidelines for the Pap test have been available
since 1997, barriers to screening remain [12].
Several strategies to improve systems-level cancer screening
rates employ evidenced-based practices (EBP) [15]. Clinical deci-
sion support (CDS) has been particularly effective in achieving
greater levels of health care EBP. In randomized controlled trials,
90% of clinician-directed CDS interventions display signiﬁcantly
improved patient care’’ [15,16]. However, few studies exist that
show the impact of clinical decision support and information sys-
tem (IS) applications—designed speciﬁcally to aid in meeting EBP
guidelines and performance benchmarks—on community health
center (CHC) colorectal, breast, and cervical cancer screening prac-
tices [17].
According to the February 2010 Patient Protection and the
Affordable Care Act, CHC’s play a critical role in providing quality
care in underserved areas and to vulnerable populations [18].
About 1250 CHC’s currently provide care to 20 million people at
more than 7900 service-delivery sites, with an emphasis on pre-
ventive and primary care [18,19]. At least one CHC is located in
every U.S. state, the District of Columbia, Puerto Rico, the U.S.
Virgin Islands, and the Paciﬁc Basin [19]. Slightly more than half,
or 52%, of these centers serve rural America, with the remainder
serving urban communities [19]. Over 45% of CHC patients partic-
ipate in Medicaid, Medicare, CHIP (Child Health Insurance Protec-
tion), or some other form of public insurance, and nearly 40% are
uninsured [19].
The Health Disparities Cancer Collaborative (HDCC) was a qual-
ity-improvement program designed to increase the cancer control
activities of screening and follow-up among underserved popula-
tions. It operated from 2003 to 2005 among CHC’s supported by
the Health Resources and Services Administration (HRSA) and
National Cancer Institute (NCI) to serve ﬁnancially, functionally,
and culturally vulnerable populations [20,21].
A sampling of 44 CHC’s were chosen to examine organizational
structure, level of implementation of Chronic Care Model compo-
nents, and contextual factors (e.g., teamwork and leadership)
[22,23]. The 2006 HDCC survey administered to community health
centers captured organizational factors, patient characteristics, and
provider characteristics that affected cancer screening quality out-
comes. The survey respondent categories included (1) director
(CEO) role, (2) chief ﬁnancial ofﬁcer (CFO) role, (3) provider (phy-
sicians, nurses) role, (4) general staff (e.g., lab, pharmacy, etc.) role,
and (5) informatics ofﬁcer (CIO) role. Topics such as clinic pro-
cesses, management strategies, community outreach, information
systems, leadership, and teams were explored. In an earlier study
[24], we identiﬁed 99 unique questions and grouped them into
37 summary measures based on internal advisory team and sub-
ject matter expert recommendations. We calculated a consensus
score for each of the 44 community health centers on each
summary measure. The conceptual model—a modiﬁed Zapka
framework henceforth referred to as the Zapka et al. framework
[25–27]—outlines the complete list of summary measures, their
respective categories (e.g., organizational, patient, or provider),
and the overall study design (see Fig. 1).
We employed two types of modeling in this secondary analysis
of the NCI/HRSA HDCC survey data. Through empirical statistical
modeling, the impact of clinical decision support use on cancer
screening quality outcomes was examined reﬂected in the rela-
tionship between our proximal and distal outcomes. Then, compu-
tational modeling was used to examine the same phenomenon
over a ten-year simulated period and generate hypotheses about
CHC cancer screening behaviors in presence of CDS.2. Rationale for a dual modeling approach
Since the American health care system is layered, ‘‘build[ing] a
research foundation that acknowledges this multilayer world’’ [28]
is essential, and traditional modeling methods may fail to ade-
quately capture its complexity. Further, practices inconsistent with
evidence persist since evidence-based innovations are not readily
accepted, and new technologies require 17 years on average to
become widely adopted [28].
Recognizing these limitations, the National Cancer Institute and
the Institute of Medicine are now encouraging a systems-thinking
approach, which the NIH’s Ofﬁce of Behavioral and Social Sciences
Research (OBSSR) deﬁnes as follows:
Systems-thinking (systems-science) is an analytical approach
that addresses a system and its associated external context as
a whole that cannot be analyzed solely through reduction of
the system to its component parts. Systems science methodolo-
gies provide a way to address complex problems, while taking
into account the big picture and context of such problems.
These methods enable investigators to examine the dynamic
interrelationships of variables at multiple levels of analysis
(e.g., from cells to society) simultaneously (often through causal
feedback processes), while also studying the impact on the
behavior of the system as a whole over time [29].
One methodology available for investigating and analyzing
complex systems is computational modeling, which employs com-
puter-based simulations, probabilistic models of systems or pro-
cesses that emulate and so predict real-world behavior under
varying assumptions and conditions. Simulation analyses provide
a basis for developing hypotheses which can then be tested in
actual intervention studies and/or technology implementations
[30]. Computational modeling is becoming an increasingly trusted
tool for analyzing complex, dynamic, adaptive, and nonlinear pro-
cesses. By permitting investigation of their functioning, it
addresses questions that traditional statistical methods alone
cannot.
Groups, teams, organizations, and organizational command and
control architectures [30] comprise one type of system to which
computational modeling is being applied in order to discover
new concepts, theories, and knowledge about them. Group or team
behavior emerges from interactions within and between the agents
or entities which comprise it. Not only humans but also objects,
locations, methods, knowledge, and motivations may be consid-
ered as agents or entities making up such a system. Identifying
key factors that contribute in varying degrees toward both individ-
ual and group-level actions is an important objective of such explo-
ration [30].
In this study, a single point-in-time HDCC survey of CHC cancer
screening practices was considered insufﬁcient evidence to dem-
onstrate the extent to which (1) the utilization of CDS impacts
facility-level cancer screening improvement and (2) the 37 sum-
mary measures (i.e., organizational and/or practice factors, patient
characteristics, and provider characteristics), singly and/or in inter-
action, contribute to continued CDS utilization over time. There-
fore, we selected computational modeling to incorporate
systems-thinking into this study.
The computational model’s main performance measures are the
rates at which knowledge is acquired and at which learning subse-
quent to the acquisition of knowledge occurs. These learning rates
are evidenced by (1) by the level of efﬁciency the model’s agents
(organizations, roles, or objects) demonstrate in performing can-
cer-screening-speciﬁc tasks following the introduction of CDS
and (2) the extent to which these agents utilize a set of deﬁned
knowledge resources designated as critical to overall community
health center (CHC) cancer screening performance. Within the
Fig. 1. Conceptual model.
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performance can be viewed as a function of task performance and
knowledge absorption over time and will be referred to as delta k
(Dk).3. Methodology
3.1. Statistical model: assessing the impact of CDS on cancer screening
in community health centers
Each community health center received a composite score on
each of the 37 summary measures describing the community
health center cancer screening practices (e.g., organizational and/
or practice setting, provider characteristics, and patient character-
istics). All of these 37 measures were used to describe overall CHC
organizational behavior and also informed the construction of our
‘‘virtual’’ CHC used in the computational modeling section. The two
outcome measures were used to determine the health center rela-
tive performance rankings ranging from high to low on each mea-
sure. Each health center was ranked based on the number of CDS
components the facility had in use at the time of the survey,
ranging from 0 to 4 for having none, one, two, three, or all fourof the CDS components, respectively (e.g., (1) capacity of informa-
tion systems to measure cancer screening, (2) use of provider
prompts at point-of-care, (3) use of clinical reminders, and (4) abil-
ity to generate electronic correspondence to patients). In our
model CDS ‘‘performance’’ was directly related to the CDS score.
The facilities were also be ranked based on their performance for
the 12-month provider self-reported cancer screening improve-
ment scores from 0 to 3, where ‘‘0’’ represented self-reported
improvement in none of the areas of breast, cervical, and colorectal
cancer; ‘‘1’’ represented self-reported improvement in only one of
those areas; on up to having provider self-reported improvement
in all three areas. In our model cancer screening ‘‘performance’’
was also directly related to this score. The computational modeling
exercise made use of these same two rankings to form a perfor-
mance matrix and grouped the 44 CHC’s into categories of high
performers vs. low performers. This portion of the study will be
discussed in detail in the computational modeling methods section
below.
3.1.1. Independent measures
Four separate types of CDS were used in the study in the
design a single composite construct to represent community
health center activity. The ﬁrst variable was labeled as the
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dents indicated (yes/no) whether their health center’s computer
system had the capacity to measure cancer-screening activities.
Cancer Screening Activity was operationally deﬁned in the sur-
vey to include providing timely notiﬁcation of screening results,
timely completion of additional diagnostic testing after abnormal
screening results, a timely beginning of treatment, and docu-
menting discussions about cancer screening [31]. A second and
third independent variable measured (yes/no) whether provider
prompts were used at the point-of-care and whether (yes/no)
computerized patient reminders were in use at their health cen-
ter, respectively. A fourth independent variable measured (yes/
no) whether their facility could generate correspondence through
the information system that reports cancer screening results to
patients.
Consistent with the Chronic Care Model, the ﬁrst three of the
four components of the composite independent variable were
labeled as clinical decision support (CDS) activity, and the fourth
of these dependent variables was considered information systems
(IS) activity. We used CDS to represent the composite construct of
CDS/IS as deﬁned by the Chronic Care Model. A score of ‘‘0’’ or ‘‘1’’
was assigned to each of the four CDS component independent vari-
ables for each facility. Each community health center was then
given a composite score for overall CDS level of use ranging from
0 to 4 for having none, one, two, three, or all four CDS present in
their health center.3.1.2. Dependent measures
Each community health center responded to the survey item
asking providers if their facility had achieved cancer screening
improvement over the preceding 12-month period in their facil-
ity-level colorectal, breast, and/or cervical cancer screening. The
12-month cancer screening improvement composite score/ranking
(0–3) represents improvement in no area, only one area (breast,
cervical, or colorectal cancer screening), two areas, or all three
areas targeted in the Community Health Center Health Disparities
Cancer Collaborative.3.1.3. Modeling approach
Spearman’s Rho Coefﬁcient was employed to test association for
CDS intensity-of-use and 12-month cancer screening improvement
scores. This correlation is designed to test the strength of relation-
ship between CDS use and cancer screening self-reported improve-
ment. This measures the relative unit increase in CDS use ranking/
scores and that of cancer screening improvement ranking/scores.
Spearman’s Rho Correlation Coefﬁcient reveals direction and
strength of the relationship. Assuming a 0.05 signiﬁcance level
and 44 observations, a bivariate correlation of .41 will result in a
power of .80 for testing the bivariate association between CDS
intensity-of-use on cancer screening performance within health
centers.3.1.4. Statistical model results
At q = 0.103, the calculated Spearman’s rank correlation
coefﬁcient between ranked facility-level number of CDS compo-
nents and self-reported 12-month cancer screening improvement
scores for colorectal, breast, and/or cervical cancer screenings
was not statistically signiﬁcant (p = 0.513) as seen in Table 1.
Therefore, no measurable association between CDS level of use
and cancer screening improvement within the CHC setting was
assumed.3.2. Computational model: assessing the impact of CDS on cancer
screening in community health centers as a function of learning rates
by performance levels
3.2.1. Rationale for using construct-TM to model community health
center cancer screening performance
The phase of the study presented herein was a further explor-
atory analysis designed to discover hidden relationships and
generate hypotheses concerning the contributions of model ante-
cedents—deﬁned in the context of this phase of the study as agents,
tasks, knowledge, or beliefs—on community health center CDS
intensity–of–use and cancer screening practices. It employed a ser-
ies of probabilistic simulations.
To conduct the simulations comprising the second phase of our
study, we selected Construct-TM, a multi-agent computational
model designed to simulate the co-evolution of agents and socio-
cultural environments [32]. It was developed by Computational
Analysis of Social and Organizational Systems (CASOS), and, like
other CASOS applications, Construct-TM incorporates network the-
ory [30,33–36].
The TM in Construct-TM’s name references the model’s inclu-
sion of transactive memory, the ability of model entities ‘‘to know
and learn about other members of the group’’ [36]. Simulated
‘‘individuals and groups’’ within Construct-TM ‘‘interact to com-
municate, learn, and make decisions in a continuous cycle’’ as they
do in real-world organizational structures. ‘‘Social, knowledge and
belief networks co-evolve’’ through this process. Reﬂecting the
transactive nature of real-world constructs, Construct-TM can
therefore be described as ‘‘a multi-agent model of network evolu-
tion‘‘ [36].
Construct-TM is speciﬁcally designed ‘‘to capture dynamic
behaviors in organizations with different cultural and technologi-
cal conﬁgurations, as well as model groups and organizations as
complex systems’’ [32]. Carley et al. explains that Construct-TM
is useful in this kind of analysis ‘‘due to its ability to manipulate
heterogeneity in information processing, capabilities, knowledge,
and resources revealed organizational settings,’’ and in doing so
Construct-TM is better able to capture ‘‘the variability in human,
technological, and organizational factors’’ [32]. The CHC data
obtained in the NCI/HRSA HDCC organizational survey results ﬁt
this description [31]. Further suiting it to the modeling of this data,
Construct-TM employs as agents decision-making units represent-
ing several levels of analysis—individuals, tasks, groups, and ﬁrm–
level [32]. This study employed a speciﬁed subset of Construct-TM
capabilities and is intended as a demonstration or proof-of-concept
in the eventual use of network evolution methodology in the areas
of technology use and/or adoption, cancer-related outcomes
research, and health information technology applications
development.
According to Carley, Construct-TM can employ any or all of
three models—(1) the standard interaction model, (2) the standard
inﬂuence model, and (3) the standard belief model [37,38]. This
study relied heavily on the standard interaction model because
summary measures such as senior leadership, clinical leadership,
and team activities are assumed responsible for the CHC values,
beliefs, and attitudes that modify agent behavior and contribute
to the within-CHC exchange of knowledge on health center cancer
screening performance, strategies, and priority areas. This study
also extensively employed Construct-TM’s standard inﬂuence
model because summary measures related to provider perceptions,
cancer screening reporting behaviors, delivery system design, out-
side collaboration, and quality-improvement strategies are
assumed to shape the extent to which an agent can be inﬂuenced
by others within the health center environment. Since the sum-
mary measures provided limited knowledge of the derivation of
Table 1
Statistical Model Results of Impact.
Spearman correlation coefﬁcients Prob > |r| under H0: Rho = 0 number of observations
YCDS YCSI
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belief model was minimal.
In the model formulation, two principles were assumed to gov-
ern behavior of CHC agents. One was homophily, the degree to
which they were drawn together by particular domains of exper-
tise, activity, or set of organizational practices; this was viewed
as a critically important driver of interaction in the simulated net-
work. The principle of inﬂuenceability, the degree to which agents
are inﬂuenced by others, was also seen as critical in shaping agents’
behavior over time within the simulated CHC environment.
Carney et al. describe the staging of the data for input into
Construct-TM, as well as details on the modeling methods, task
deﬁnitions, knowledge deﬁnitions, and performance level descrip-
tive statistics [39]. The focus of this manuscript will be on the com-
parative results of the two types of modeling used in this dual
modeling experimental design.
Each HDCC survey summary measure was converted into one of
four representative Construct-TM categories (i.e., agent, task,
knowledge, or belief) in a process not unlike that Effken et al.
employed in their analysis using another CASOS tool developed
by Carley et al. and called OrgAhead to map nursing quality catego-
ries (i.e., organizational characteristics, patient characteristics,
patient outcomes, and patient unit characteristics) into the simula-
tion tool [40,41]. As such, each of the 37 HDCC survey summary
measures in this study would be assigned an identity from among
one of the following: a representation of knowledge, a task, an
agent, or a belief. We used a subset of the 37 measures to more
speciﬁcally represent the cancer screening test agent used in our
simulation (as seen in Table 2). This corresponding identity would
consist of a set of formalized deﬁnitions and parameters governing
its behavior throughout the simulation. These mappings were
guided by the internal advisory team and subject matter experts.
This study design allows for multiple scenarios to be tested
under varying and virtually limitless conditions. To generate new
hypotheses about a given phenomenon, trial and error would seem
to be an obvious but possibly fruitless approach. However, Carley
et al. stress the value of the more dynamic hypothesis-generating
methods made possible by computational models in building
new concepts, theories, and knowledge about complex systemsTable 2
List of cancer screening test agent variables and assumptions.
Agent categories Task knowledge impacting
performance is informed by
Knowledge a
is informed b
Cancer screening test (CST)  Clinic processes  Work impo




 CDS practices  Cancer scre
facility leve
 Information dissemination strategies  Patient dem
– Patient age
– Patient lang[30]. They postulate the existence of some simple but nonlinear
process underlying individual, team, group, or organizational
behavior [30] that computational modeling can reveal but that
basic tests of statistical associations may not. Thus, applying a
computational model to point-in-time survey data—not originally
designed to inform network analysis—such as that used in this
study allows analysis beyond the original intent motivating the
survey and provides almost limitless possibilities for exploratory
analysis.3.2.2. The computational modeling process
Our computational modeling process included two steps. The
ﬁrst involved grouping the community health centers based on
the conceptual model’s two major outcomes—CDS community
health center intensity–of–use (its chief proximal outcome) and
facility-level breast, cervical, and colorectal cancer screening
improvement (its chief distal outcome). The statistical model
treated these as two separate measures and employed their rank
correlation to measure the strength of their relationship. In that
analysis, the correlation served as a proxy to measure overall
impact of CDS on cancer screening improvement.
For use in the computational model, we assigned a composite
performance level to each CHC based on its location in the graph
shown below. The CDS intensity-of-use measure, ranging from 0
to 4, forms the matrix x-axis, and the cancer screening improve-
ment score, which can range from 0 to 3, forms its y-axis. The
resulting matrix was divided into high, medium, and low regions
for each measure. A CHC could then be assigned a qualitative,
two-part coordinate based on its position, and this coordinate
formed the unit of analysis of the virtual CHC’s within Construct-
TM. Figs. 2 and 3 display the distribution and plot matrix of CHC’s
within this qualitative measure, respectively.
In the second step, Construct-TM’s virtual health centers were
parameterized using the normalized HDCC survey responses to
each of the 37 summary measures (i.e., organizational, patient,
and provider level factors). CHC behavior by performance level
was determined by the survey questions’ possible values and their
corresponding observed frequencies.bsorption (Homophily knowledge)
y
Rationale and/or assumptions
rtance of cancer screening tests  Cancer screening test (CST) represents a
non-human agent
ening rate reporting behavior
el
 CST agent is active all the time
ening rate reporting behavior
l




 CST Agent cannot initiate interaction
Composite 
Performance  
Level Measure Position Description Frequency 
High/High (HH)  Top Right Ideal 24 
Medium/High (MH) Top Center Moderate 5 
Medium/Low (ML)** Bottom Center Moderate 1 
High/Low (HL) Top Left Mixed 3 
Low/High (LH) Bottom Right Mixed 6 
Low/Low (LL) Bottom Left Less than Ideal 3 
*No health centers were assigned to permutations not shown (e.g., HM, MM). 
**Since only one health center occupied this level, Medium/Low was not included in the 
final analysis. 
Fig. 2. Basis of performance level assignment to community health centers.
Fig. 3. HDCC performance level grid.
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measures to one or more of Construct-TM’s four categories—agent,
task, knowledge element, and/or belief—from the HDCC survey
respondents’ perspective or that of one of the deﬁned agent classi-
ﬁcations. Within the Construct-TM model, an agent is an entity to
whom knowledge can be communicated. The following summary
measures from the HDCC survey data were interpreted as knowl-
edge communications to cancer screening agents: (1) work impor-
tance of cancer screening tests, (2) provider-level cancer screening
rate reporting behavior, (3) facility-level cancer screening rate
reporting behavior, (4) patient demographics-patient age, and (5)
patient demographics-patient language. Table 2 lists variables
from among our 37 summary measures, along with the key
assumptions we used in our simulation to inform the ‘‘cancer
screening test (CST) agent’’ classiﬁcation. The selection of these
variables to described agent behavior was done in conjunction
with the internal research advisory team and subject matter
experts informing the simulation design. The purpose of this study
was to examine CST agent as it was projected to be inﬂuenced by
CDS exclusively for comparison with our Spearman’s Rho test.
Our companion manuscript highlighted the use of all ﬁve our agent
classiﬁcations including provider perspective, administrator per-
spective, collaborator perspective, health information technology
perspective, and CST perspective [39].
The ﬁnal step was to complete the transformation of the HDCC
survey data for input into Construct-TM. We created an Excel
Spreadsheet Code Generator developed by programmers at CASOS
to input our variables, assumptions, and deﬁnitions that were then
automatically converted into Construct-TM XML coded input deck.
Information input into the model in mathematical form consistedof (1) a glossary of the simulation’s variables, (2) agent, knowledge,
and task deﬁnitions, (3) deﬁnitions of model nodes, to which sim-
ulation entities are assigned, and (4) types of networks to be used.
For more details on this facet of the study please see our compan-
ion manuscript [39]
3.2.3. Computational model results: ten-year performance of cancer
screening agent simulation
Twenty-ﬁve runs were conducted on each of the ﬁve perfor-
mance level groupings. The two-part performance levels, displayed
in Fig. 2, were derived from high, medium, and low levels of the
two variables, CDS intensity–of–use and cancer screening improve-
ment. The simulation’s measure of interest was the group cancer-
screening agent’s rate of knowledge absorption over time, referred
to as delta k (Dk). Fig. 4a–e shows the results for each individual
performance level and Fig. 5 displays the group mean Dks calcu-
lated from 25 simulation runs over a 10-year period.
4. Dual modeling discussion
4.1. Statistical model: on tests of statistical signiﬁcance as a means of
impact
Our statistical analysis did not demonstrate any signiﬁcant
association between facility-level rankings for intensity-of-use of
CDS and the rankings of facility-level provider self-reported cancer
screening improvement scores within health centers. This study’s
ﬁnding was consistent with the mixed results of previous studies
that did not always demonstrate a signiﬁcant relationship between
HIT of any kind and health outcomes in general, and cancer screen-
ing, in particular [42–44]. There may also be additional human,
organizational, and/or socio-technical factors that confound the
relationship between CDS and cancer screening [45] that were
not measured in the current study. High-yield targets for future
interventions or studies would include human factors analysis
(e.g., computer interface issues), as well as facility, and/or pro-
vider-level incentive programs [46–48]. Our use of the computa-
tional modeling in tandem with this statistical analysis was
intended to generate hypotheses and explore alternative ways of
examining the same set of factors in explaining overall
performance.
4.2. Computational model: viewing the community health center as a
learning organization
The virtual experiments that these simulation runs represented
were intended to predict relative change of a CHC’s performance
level of group knowledge absorption over time, termed its delta k
(Dk). In the simulation, the cancer-screening agent’s Dk, evaluated
(a) High/High CHC Performance Level (b)  Medium/High CHC Performance Level 
(c) High/Low CHC Performance Level (d) Low/High CHC Performance Level 
(e) Low/Low CHC Performance Level 
Fig. 4. (a–e) 10-year Simulation Knowledge Absorption Rates by CHC Performance Level.
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Fig. 5. All CHC performance Level 10-year comparison of means.
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edge-exchange opportunities only, was captured at 520 intervals,
representing weeks in a 10-year period. We hypothesized that
the original scores used to designate high-performing CHC’s would
be associated with relatively higher rates of knowledge absorption
Dk than the scores designating low-performing ﬁrms over the
10-year period.
Previous studies identiﬁed metrics for organizational learning
and described them in terms of clinical ‘‘know-how’’ [49], collec-
tive intuition [50], and overall organizational learning and/or orga-
nizational intelligence [51–54]. The ﬁndings derived from these
simulations were consistent with previous studies that argued
the following: (1) Organizations change over time; (2) a positive
correlation exists between the rate of organizational learning and
some measure of performance/success; (3) health information
technology used in support of cancer outcomes should take into
account the learning required to improve organizational capabil-
ity; and (4) the health care facility should be viewed as a complex
adaptive environment [51,52].4.3. Ten-year performance of cancer-screening agent simulation
The stark contrast in rate of knowledge absorption between
high- and medium-CDS groups on the one hand and low-CDS
groups on the other is demonstrated by the relative steepness in
slope of the former’s averages charted over time. Further, the rate
of knowledge absorption with respect to cancer screening
improvement within the two clusters showed greater intra-cluster
than inter-group consistency. Fig. 5 reveals two clearly distinct
knowledge-absorption performance subgroups—high-level per-
formers (e.g., HH, MH, and HL) versus low-level ones (e.g., LL, LH).
Through task knowledge’s impact on performance, this simula-
tion and succeeding analysis of its results examined the cancer-
screening agent’s knowledge absorption when CDS was in use to
support cancer-screening activities over the 10-year or 520-week
period. Observing the 25-run, weekly average Dk of its cancer-
screening agent for each of the ﬁve CHC performance levelssimulated over a 10-year period revealed two major perfor-
mance-level clusters with respect to knowledge absorption over
time, or Dk. Speciﬁcally, these agents fell into sets of either high
or low performers based solely on Dk over the 10-year period. This
clustering effect was in addition to their original designations at
the start of the simulation. The clustering observed at the simula-
tion’s conclusion was based solely onDk and represented a distinct
difference in low and high performers with regard to this metric.
Two observations regarding this clustering effect are noteworthy.
First, those ﬁrms ranking higher for CDS use at the simulation’s
start belonged to the high-Dk cluster at its end, and ﬁrms marked
lower at its start belonged to the low-Dk cluster at simulation end.
Speciﬁcally, member ﬁrms ranked low in CDS utilization at simula-
tion start and so classiﬁed as LL or LH were found to be members of
the low-Dk performance cluster at simulation end. Members of the
high-performing levels, rated as medium or high with respect to
CDS utilization, were observed to be members of the high-Dk per-
formance cluster at simulation end. The ﬁnding of a positive corre-
lation between original performance level rankings with respect to
CDS utilization and the 10-year Dk was consistent with previous
ﬁndings that differentiated performance levels for HIT use in sup-
port of clinical outcomes into groups of high performing and low
performing medical groups [55].
This clustering effect was also observed with regard to the
second metric used in our initial classiﬁcation by performance
level—cancer screening improvement with respect to breast, cervi-
cal, and colorectal cancers. Within this category, opportunities for
knowledge sharing, learning, and exchange also existed, and those
CHC’s ranked higher in cancer screening self-reported improve-
ment at simulation start also showed simulation-end clustering
by level of knowledge-absorption proﬁciency Dk.
Second, not only was the amount of variation observed between
the high- and the low-Dk clusters itself dramatic in its size, but
there existed much more variability between the two clusters than
was observed between the individual members of each cluster. In
fact, the Dk’s of the high/high and high/low CHC’s were almost
indistinguishable at the end of Year 10, and themedium/high CHC’s’
Dk’s were extremely close in size to theirs. In the low-Dk cluster,
the low/low CHC’s presented at the bottom with the lowest 10-year
Dk, and the CHC’s ranked low/high displayed only a slightly higher
10-year Dk. These ﬁndings were consistent with those observed in
previous research where a positive correlation between the rate of
organizational learning and some measure of performance/success
was asserted [51].
These ﬁndings were consistent with studies that measured the
concepts of organizational intelligence, intuition, and clinical
‘‘know-how,’’ all of which represent varying ways of measuring
organizational learning over time [49,50]. Speciﬁcally referencing
clinical ‘‘know-how’’ and discussing its relationship to quality, efﬁ-
ciency, and safety in clinical care, Anderson et al. found that clinical
decision support contributes to it positively [49]. A closely related
concept is intuition. Salas et al. suggested that ‘‘decision-task’’ and
‘‘decision-environment’’ are part of an overall understanding of
intuition within an organization [50].
This study used Dk as an overall measure of the virtual commu-
nity health center clinical know-how and the related concept of
intuition and as a metric of overall organizational learning over
time. Deﬁning a concrete measure consistent with clinical know-
how and/or organizational intuition that would serve as their
proxy in distinguishing high-learning organizations from low-
learning ones over a 10-year period was this study’s intent. Thus,
study results are consistent with the notion put forth by Feifer
et al. [51], that a correlation exists between the rate of learning,
as measured in this simulation by Dk or rate of knowledge absorp-
tion, and performance, as measured by its proxies CDS use and
cancer screening self-reported improvement scores for breast,
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ing a computational model to this study was (1) we were able to
successfully simulate a correlation between the use of CDS and
cancer screening performance where a statistical model showed
no such correlation, (2) we successfully built this model on a
point-in-time data source that represented a ‘‘snap shot’’ and pro-
ject performance over an extended period of time, and (3) by pro-
jecting high vs. low performance into the future, we were able to
identify parameter boundaries for each of these 37 summary mea-
sures to inform continued monitoring and tracking of performance
meeting long-term health care quality objectives.5. Conclusions
Combining statistical and computational models to create a
dual modeling approach can be essential to deﬁning critical associ-
ations with respect to clinical decision support outcomes and can-
cer screening improvement. This approach allows associations that
can successfully predict high performance versus low performance
over an extended period of time to be tested in a virtual environ-
ment. Riegelman et al. suggest that systems-thinking is understood
by contrasting it with the traditional (i.e., statistical modeling)
[56]. Although the computational modeling portion of the research
can be considered as a hypothesis-generating exercise, it can also
be viewed as a hypothesis test in its own right, where the hypoth-
esis being tested was that measurable change in knowledge
absorption Dk over time by performance level occurs with respect
to cancer screening and CDS use. Since the model’s high-
performing CHC’s exhibited a correspondingly higher rate of
knowledge absorption over a simulated 10-year period than did
low-performing ones, study results supported this hypothesis.
Despite varying evidence showing that CDS can have positive
impacts on clinical and process performance measures our study
was unable to duplicate this using statistical tests of correlation.
However, in the construction of a ‘‘virtual experiment’’ using com-
putational modeling methods, network theory, and simulation we
were able to take the same data and examine the relationship in
different way. We contextualized the variables of CDS and cancer
screening on the basis of performance and learning as a means to
more closely examine the potential impact of CDS on cancer
screening behaviors. Our assumption was that the use of CDS
should improve performance of the cancer screening task, and that
such performance improvement should be measured in the rate of
knowledge absorbed through the interactions among agents in the
network. We successfully demonstrated through our computa-
tional models that the level use of CDS and its correlate cancer
screening improvement score, indicated by performance level at
the start of our simulation, were both highly associated with
increased rates of learning. Thus, one critical hypothesis generated
from our study is that impact studies of HIT such as CDS on clinical
and organizational outcomes might be better observed in the con-
text of agent learning (expressed as knowledge absorption) related
to task performance. Our study contributes by providing evidence
of the value of this dual modeling design.6. Limitations
In terms of the statistical model we were challenged by the use
of the provider self-reported cancer screening improvement scores
as opposed to the actual facility-level cancer screening rates. Self-
reported screening improvement may be subject to reporting bias.
Prior research indicates that patient’s reports of cancer screening
may overestimate the receipt of screening [57]. However, the ques-
tion was asked here of all community health centers participating
in the organizational survey, and thus, it is unlikely to be biasedwith respect to any particular factor tested in the statistical or com-
putational models. Furthermore, primary care practices are subject
to multiple performance measurement and quality improvement
programs related to screening and prevention and so it is quite pos-
sible that the community health centers surveyed here have inter-
nal data to inform their answer to these questions. On the other
hand, this organizational survey did not represent a quality
improvement tool itself, and no ﬁnancial incentives were delivered
based upon the performance described in these self-reports. For
this reason, there is no particular motivation for providers to inﬂate
their reports of screening behavior. Prior studies of clinical vign-
ettes have demonstrated that individual health care providers
self-reported clinical behavior is commonly consistent with clinical
practice as assessed by medical record review [58,59].
In terms of computational model, limitations revolve around
volume, model applicability, and validation. Any simulation
beneﬁts from rich, robust, and exhaustive data. Increases in data
available to support assumptions translate into a more robust sim-
ulation model. The current study’s computational analysis had only
37 summary measures as primary inputs. Greater availability of
data will beneﬁt future research.
Because this study represented a tradeoff between model gen-
eralizability and applicability on the one hand and narrow focus
on the cancer screening test agent on the other, choice of the set
of summary measures used to deﬁne each agent’s behavior was
rigorous and dramatically limited the number of ways in which
the agent learned, interacted, and evolved within the simulation.
Future research may employ less rigid criteria for inclusion of vari-
ables and/or a more sophisticated algorithm capable of testing all
or any combination of variables.
Finally, the current study did not include external validation of
the simulation model. Future studies designed solely to validate
this network evolution model as a methodological framework that
can be deployed on a larger scale are warranted.Authors’ contributions
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